Fingerprint
Dive into the research topics of 'Benefits and costs of recombinant human erythropoietin for end-stage renal failure: A review benefits and costs of erythropoietin'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Benefits and costs of recombinant human erythropoietin for end-stage renal failure: A review benefits and costs of erythropoietin
Paul McNamee, Eddy van Doorslaer, Rob Segaar
Research output: Contribution to journal › Article › Academic › peer-review
13
Citations
(Scopus)